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Abstract
For decades, researchers have sought to clarify the nature of the social communication impairments in autism,
highlighting impaired or atypical ‘social attention’ as a key measurable construct that helps to define the core
impairment of social communication. In this paper, we provide an overview of research on social attention
impairments in autism and their relation to deficiencies in neural circuitry related to social reward. We offer a
framework for considering social attention as a potential moderator or mediator of response to early behavioral
intervention, and as an early indicator of efficacy of behavioral and/or pharmacological treatments aimed at
addressing the social impairments in autism.
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Review
Recent conceptualizations of the diagnostic features of
autism spectrum disorder (ASD) emphasize two core
features: social communication and repetitive behaviors
[1]. Decades of research have sought to clarify the nat-
ure of the social communication impairments, highlight-
ing impaired or atypical ‘social attention’ as a key
measurable construct that helps define the core impair-
ment of social communication. In this paper, we provide
a brief overview of behavioral and neuropsychological
research on social attention impairments in autism and
their relationship to deficiencies in neural circuitry
related to social reward. We offer a framework for con-
sidering social attention as a potential moderator or
mediator of response to early behavioral intervention,
and a biomarkera that could potentially be useful as an
early indicator of efficacy of behavioral and pharmacolo-
gical treatments aimed at addressing the social commu-
nication impairments in autism.
Early manifestation of social attention impairments in
ASD
Typical infants show preferential attention to people,
including their eyes, faces, and movements from the
first days of life. Faces, voices, and body movements are
biologically relevant stimuli that are normally a strong
focus of attention beginning early in life. Young children
with autism, in contrast, pay less attention to other peo-
ple and their actions and focus their attention instead
on non-social objects [2]. Three to four-year-old chil-
dren with ASD fail to show normal preferences for
speech sounds [3-5]. Pierce et al. [6] reported that tod-
dlers with ASD, aged 14 to 42 months, prefer to visually
examine geometric images more than social images.
Chawarska et al. [7] found that, unlike toddlers with
typical development or developmental delay, toddlers
with ASD did not have difficulty disengaging their atten-
tion from a face when presented with a competing sti-
mulus. Impaired eye contact is an early emerging,
cardinal feature of ASD present by at least 1 year of age
in children with early onset autism [8,9]. A failure to
orient to social stimuli, termed a ‘social orienting
impairment’ was documented in preschool-age children
with autism decades ago [10] and was subsequently
demonstrated in 10-month-old infants who go on to
develop autism [8]. More recently, Klin et al. [11]
reported that 2-year-olds with autism orient to non-
social contingencies rather than biological motion.
To help explain the impairment in social attention
found in autism, Dawson and others have proposed the
social motivation hypothesis, which posits that autism is
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associated with reduced social reward sensitivity mani-
fest in a failure to affectively tag socially relevant stimuli
[12-15]. Diagnostic criteria for autism describe ‘a lack of
spontaneous seeking to share enjoyment, interests, or
achievements with other people’ and ‘lack of social or
emotional reciprocity.’ For example, preschool-age chil-
dren with ASD are less likely to smile when looking at
their mothers during social interaction [16], especially
during joint attention episodes [17]. Related to this,
Sung et al. [18] found evidence that a diminished social
motivation trait (for example, seeking social activities
and friendships) was heritable (heritability estimate =
0.19) in multiplex autism families.
It has further been hypothesized that reduced social
attention has potentially negative downstream conse-
quences for social and language development and learn-
ing, in general, affecting the development and
specialization of neural circuitry subserving these
domains, which is experience-dependent [19-21]. It has
been hypothesized that early behavioral intervention can
mitigate these negative consequences by enhancing
social motivation by either stimulating nascent neural
circuitry involved in social reward, or by co-opting
neural reward systems that target non-social stimuli
through classical conditioning (non-social reward, such
as food or a toy, being paired consistently with a social
stimuli, such as person in the context of treatment) [19].
Neural mechanisms involved in reward processing and
implications for ASD
Although there has been limited work conducted exam-
ining the neural correlates of reward processing in ASD,
the existing findings from functional MR imaging, elec-
trophysiological, and neuropsychological studies have
informed our understanding of the neural mechanisms
related to both social and non-social reward processing
in ASD.
Functional imaging studies in typical populations have
identified several key brain regions involved in reward
processing. The anterior cingulate cortex (ACC) and
orbitofrontal cortex (OFC), as well as regions involved
in the mesolimbic dopamine system, which originates in
the ventral tegmental area (VTA) and projects to the
nucleus accumbens (NA) in the ventral striatum, have
long been associated with reward processes. These
regions have consistently been associated with the
rewarding properties of alcohol and drugs [22], food
[23,24], sex [25], and monetary gain [26-28]. Further,
functional imaging studies implicate this system and
these structures during the viewing of social stimuli
such as faces [29-33] or when receiving social reinforce-
ment [34].
Functional imaging studies with individuals with ASD
have indicated differential functioning of these neural
regions implicated in reward processing. Increased acti-
vation in the left ACC and left middle frontal gyrus was
observed in a sample of high functioning adults with
ASD during a target detection task yielding monetary
rewards [35]. Further, the activation in the left ACC cor-
related with degree of social symptomology, as measured
by parent interview, suggesting that disruptions in this
structure of the reward system may contribute to the
social deficits observed in ASD. Reductions in ACC
volume and white matter have also been observed in
ASD indicating structural differences in this region
[36,37]. A recent study of 92 high-risk infant siblings
demonstrated that those infants who eventually devel-
oped ASD exhibited diffuse aberrant development of
white matter pathways between 6 and 24 months of age,
based on diffusion tensor imaging. These results suggest
that alterations in ACC white matter (as well as other
white matter fiber tracts) may be present very early in
life. School-aged children with ASD have demonstrated
differential neural activity in response to monetary
reward as well as social rewards. Children with ASD
showed reduced neural activity in the ventral striatum
in response to both monetary and social rewards pro-
vided during an abstract figure classification task. They
demonstrated reduced activity in the ACC, the striatum,
and ventral prefrontal cortex during the learning process
but only in the social reward condition, not the mone-
tary learning condition [38]. Children with ASD have
also demonstrated reduced neural activity in these fron-
tal circuits and the striatum compared to typically devel-
oping children during social cuing tasks, suggesting that
social cues are not afforded the same neural importance
in ASD as they are for typical children [29]. However,
typical activation of the nucleus accumbens has also
been observed in adults with ASD when the reward sti-
mulus is an object of specific interest. Dichter and col-
leagues [39] rewarded participants with either money or
pictures of favored objects (such as trucks and mechani-
cal devices) in response to quick button-press responses
to a bulls-eye target. When anticipating or receiving a
monetary reward, ASD adults showed reduced activation
in the nucleus accumbens compared to controls. How-
ever, when the object reward was provided, the ASD
adults showed a similar level of reward system activation
to the typical controls. The limited imaging findings in
the literature indicate differential activation in reward-
related neural structures in ASD for a variety of stimu-
lus types and notably for social stimuli.
Electrophysiological studies have also revealed atypical
functioning of the reward system in ASD in relation to
processing social or non-social stimuli. EEG provides
insight into the temporal dynamics of brain activity that
functional magnetic resonance imaging (MRI) studies
are unable to elucidate. Event-related potentials (ERPs)
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can be derived from EEG recordings, and reflect the
averaged brain response to a single stimulus event that
is repeatedly presented. Several measures can be derived
from the ERP, including the latency and amplitude of
the different positive- and negative-going peaks of the
ERP wave form. Different peaks of the wave form reflect
different processes, such as attention, memory, expecta-
tion, and so on.
An incentivized go/no-go task adapted for ERP studies
has provided a paradigm for examining reward anticipa-
tion as both social and monetary rewards increase the
accuracy of the inhibited response in typical individuals
[40]. The amplitude of the P3, a positive-going peak
occurring approximately 300 ms after stimulus onset,
has been used as an indicator of motivational salience,
with greater amplitudes indicative of increased reward
value [41,42]. On an incentivized go/no-go task, children
with ASD showed an attenuated P3 amplitude response
to both social (as indicated by a picture of a smiling
face) and non-social (monetary) rewards, suggesting a
reward-processing deficit, but not one specific to social
stimuli [42]. Feedback-related negativity (FRN), an ERP
response marked by greater negative amplitude in
response to a loss, such as loss of money, than a gain,
has been shown to be typical in ASD. Individuals with
ASD show expected greater negative amplitude to
monetary losses compared to gains during learning tasks
or guessing games [43,44]. This FRN result contrasts
with findings in individuals with ASD of attenuated
amplitudes of event-related negativity (ERN) which is a
negative going wave that occurs within 100 ms of mak-
ing an incorrect response on a task [45,46], although
greater amplitudes have been noted in ASD as well [47].
Larson and colleagues suggest that this discrepancy of
findings between FRN and ERN suggest that it is not
the valence of the feedback, but the source of the feed-
back, such as social or non-social, that is the critical
component [44].
Neuropsychological studies in individuals with ASD
have also yielded insight into the mechanisms for social
and non-social reward processing. On neuropsychologi-
cal tasks reflecting functioning of ventromedial prefron-
tal cortex (VMPFC) and dorsolateral prefrontal cortex
(DLPFC), children with ASD showed similar levels of
performance relative to mental-age matched typical chil-
dren and children with developmental delay [48]. The
VMPFC tasks included delayed non-matching to sample
(DNMS) and object discrimination reversal (ODR), both
tasks shown to tap the VMPC in non-human primate
studies. The DLPFC tasks included delayed response
tasks and spatial reversal. Only performance on the
VMPFC task was correlated with severity of core autism
symptoms (joint attention ability). Given the relationship
between the VMPFC and reward processing regions
such as the OFC, this neuropsychological finding pro-
vided early evidence for a disruption in reward proces-
sing in ASD. Additionally, performance on
neuropsychological tasks that measure learning of
reward associations, such as DNMS and ODR, predict
social and communication growth rates in children with
ASD [49]. High functioning 6 to 7-year-olds with ASD
performed more poorly on a ‘hot’ executive function
(delayed gratification) task but not a ‘cold’ executive
function (dimensional change card sort) task than age-
matched typical peers, indicating that executive func-
tioning tasks that rely more heavily on the reward path-
way are more challenging for children with ASD [50].
These behaviorally-based testing results provide further
insight into the neural mechanisms for reward proces-
sing and offer additional evidence of differential proces-
sing of social and non-social rewards in ASD.
Neuropeptides involved in reward processing and ASD
Advances in research on prosocial neuropeptide systems
of the central nervous system (CNS) have offered addi-
tional insights into the molecular and cellular mechan-
isms involved in reward processes supporting social
behaviors, and may offer specific clues to the impor-
tance of these systems to the development of social
impairments in ASD. In this area of research, particular
attention has focused on evidence from studies of the
evolutionarily related nonapeptides oxytocin (OT) and
vasopressin (AVP) [51]. Across mammalian species from
rodents to humans, OT and AVP have been shown to
be powerful modulators of neural activity that regulate a
diverse range of CNS functions in both males and
females in a manner physiologically distinct from the
well-described endocrine activities of these molecules
[52,53]. In the context of reward processing, neuroana-
tomical, biochemical, and behavioral evidence have
emphasized the relevance of functional interactions
between oxytocinergic and dopaminergic neurotransmit-
ter systems of the CNS in social cognition and behavior
[54]. More specifically, a network of oxytocinergic-dopa-
minergic neural circuitry suggests a mechanism by
which OT recruits reward and reinforcement to enhance
the salience of social stimuli [55]. Individual variation in
maternal behaviors toward infants, and the involvement
of brain reward circuitry, appear to be intrinsically
linked with the development of central oxytocinergic
and dopaminergic systems [56]. Utilizing BOLD MRI in
rodents, OT administration mimics activation of the
same brain areas involved in olfactory, emotional, and
reward processing that are observed postpartum in
dams during suckling, which can be antagonized phar-
macologically by administration of an OT receptor
(OXTR) antagonist [57]. Even in nulliparous females,
OT administration increases the functional connectivity
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between key CNS structures involved in reward proces-
sing following exposure to recordings of infant laughter,
providing additional support that OT acts to enhance
the salience of social stimuli [58]. Combinatorial meth-
ods involving genomic approaches and multimodal neu-
roimaging of human adults revealed a relationship
between genetic variation in the gene encoding the OT
receptor (OXTR), and differences in reward dependence
as measured with the Tridimensional Personality Ques-
tionnaire [59]. Collectively, the extant evidence to date
would suggest that prosocial neuropeptides such as OT
engage reward circuitry of the CNS to support effects
on social functioning, and implicates this functional
connectivity in the etiology of underlying social deficits
in ASD.
Studies showing altered levels of oxytocin in ASD
A hypothesis of oxytocinergic deficiency in ASD has
emerged, and is supported by different evidence from
fields of biochemical and genetic research. Reduced cir-
culating levels of OT in plasma have been reported in
children with autism when compared to typically devel-
oping children, a finding that is correlated with greater
impairment in social skills [60,61]. Lower levels of OT
were associated with lower scores on social and develop-
mental measures of behavior. Abnormalities in the pro-
teolytic processing of the inactive precursor peptide of
OT, which is required for the production of biologically
active peptide, have also been observed in individuals
with autism and associated with lower circulating levels
of OT [61]. This suggests a diversity of risk factors may
conspire to adversely impact oxytocinergic function in
ASD. From a different perspective, numerous genetic
studies have revealed that variation in OXTR may be
also specifically associated with ASD. Adding to this,
combined analysis of linkage data from two independent
genome-wide screens of the Autism Genetic Resource
Exchange (AGRE) and a large Finnish autism cohort
identified OXTR among four susceptibility loci for aut-
ism [62]. Evidence of association between OXTR geno-
type and ASD have been observed in most, but not all
studies [63,64]. Of interest, evidence of allelic associa-
tion between OXTR and ASD has been observed across
ethnic backgrounds including Caucasian [65], Chinese
[66], and Japanese populations [67]. With respect to
social functioning in ASD, a clear association between
OXTR genotype and social endophenotypes has been
established in a large family-based study involving 2,333
individuals [68]. These data are consistent with evidence
from smaller studies suggesting that variation in OXTR
plays an important role in influencing the development
of communication, daily living skills, and socialization in
individuals with autism [69]. Intriguingly, variation in
genes encoding proteins biologically coupled to oxytoci-
nergic function has also been associated with ASD. For
example, allelic variants in the CD38 gene, encoding a
protein involved in the secretion of OT from hypothala-
mic neurons, have been identified in individuals with
ASD and are associated with reduced plasma levels of
OT [70]. Examination of postmortem brain tissue from
individuals with ASD has revealed expression differences
in OXTR that appear tied biologically to altered expres-
sion of specificity protein 1 (SP1), a transcription factor
involved in the expression of several ASD candidate
genes including OXTR [71]. Changes in the methylation
status of the OXTR promoter have also been associated
with altered expression of the receptor in the postmor-
tem brains of persons with autism, suggesting that epi-
genetic mechanisms may also be complicit in
pathogenic regulation of OXTR expression in ASD [72].
Collectively, a growing body of evidence is accumulating
that reduced oxytocinergic function may represent an
important contributing factor to an endophenotype
underlying social deficits in ASD.
Impact of oxytocin on social attention/functioning in ASD
participants
Numerous clinical studies have directly investigated
the impact of OT on social functioning in humans,
including trials with OT in individuals living with
ASD, and have provided the most compelling evidence
to date supporting a proof of concept for oxytocinergic
system involvement in social functioning. These stu-
dies have largely involved the experimental use of
intranasally administered OT, a synthetic preparation
of the peptide previously developed and approved for
use with non-CNS indications (for example lactation
support) [73]. In healthy human volunteers, a broad
range of effects have been described for OT adminis-
tration on social cognition, including improvements in
the encoding and recognition of facial expression [74],
increased empathic perception [75,76], enhanced mem-
ory encoding of faces in humans, but not of non-social
stimuli [77] and responses to biological motion [76].
Additionally, OT enhances socially-reinforced learning
[75], promotes trust [78], enhances the subjective per-
ception of attachment [79], and increases cooperative
behavior with social cues [80]. Challenge studies in
healthy volunteers also reveal pharmacodynamic effects
of OT on neural activity in many of the same CNS
structures where aberrant activity has been observed in
ASD versus neurotypical controls. For example, OT
increases functional connectivity between the amygdala
and the ACC, which suggests that this peptide acts
simultaneously to enhance neural control over negative
emotionality and increase the incentive salience of
social stimuli such as infant laughter [58]. It is possible
that OT may act at the level of specific circuits, in a
compensatory manner, to address deficits in neural
activity observed in ASD.
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Implicit in the observed effects of OT on social func-
tioning of typically developing individuals is the trans-
lational potential for oxytocin-based therapeutics as a
treatment option for addressing core social deficits in
ASD [81], and several small clinical trials have directly
investigated the clinical efficacy of OT in individuals
with ASD. Investigating comprehension of affective
speech in adults with autism or Asperger syndrome,
Hollander et al. demonstrated that infusion of OT
could significantly enhance the processing and reten-
tion of social information [82]. Other studies found
that OT increased social engagement in ASD partici-
pants. Using a social interaction task, where partici-
pants with autism engage in a simulated ball-toss game
over a computer network with three fictitious partners,
Andari et al. demonstrated that intranasal OT
increased social approach and social comprehension
[83]. Intranasal OT administration also improves emo-
tional recognition in children with ASD participating
in a Reading the Mind in the Eyes Test-Revised, one
of the most widely used tasks for examining the The-
ory of Mind [84].
In summary, there is evidence that ASD is associated
with oxytocinergic deficiency which may underlie defi-
cits in social motivation and engagement. Specifically,
ASD is hypothesized to involve deficiencies in the net-
work of oxytocinergic-dopaminergic neural circuitry by
which OT recruits reward and reinforcement to enhance
the salience of social stimuli. Early trials involving
administration of OT have shown promising results for
enhancing social approach and comprehension in ASD
participants.
Social attention as a moderator and mediator in autism
clinical trials
In light of neurophysiological, behavioral, and molecular
evidence that autism is associated with reduced activity
of social reward circuitry which are hypothesized to
underlie deficits in social motivation in ASD, there is
great interest in developing feasible, valid biomarkers
reflecting degree of social motivation that could be used
as early indicators of efficacy in clinical trials aimed at
addressing the social impairments in autism. Many stu-
dies have demonstrated that reward facilitates attention
to specific stimuli, and that reward-based priorities
strongly influence how attention is allocated [85-94].
For example, ERP measures of attention (for example
P3 ERP amplitude) have been shown to be closely linked
to reward anticipation [42], and other studies have
demonstrated that visual attention to a stimulus is
modulated by its associated value [95,96]. Research has
also shown that the magnitude of visual attention that is
created by reward is predicted by the response to
reward feedback in the ACC [89].
Measures of social attention have shown promise as
early predictive diagnostic biomarkers for ASD [6].
Here, we argue that such measures could also serve as
both an early sign of efficacy and for stratification in
clinical trials designed to enhance social communicative
behavior. A distinct advantage of measures of social
attention is their feasibility with participants of a wide
age range (infants to adults) and ability levels (non-ver-
bal and intellectually disabled to normal cognitive func-
tioning). We first consider how such measures might be
considered in the context of a clinical trial testing the
efficacy of an early behavioral intervention.
Vismara and Rogers [97] recently summarized the
extensive research literature on behavioral interventions
for children with ASD and concluded that both compre-
hensive and targeted behavioral interventions can be
effective in improving communication, social skills, and
management of problems behavior for young children
with ASD. Recent studies suggest that relatively brief
targeted interventions can significantly improve autism
symptoms in young children and toddlers with ASD
[98-100]. As described by Dawson [19] and as illustrated
in Figure 1, early behavioral intervention serves to alter
children’s sensitivity to social reward and, thereby, alter-
ing levels of social attention. Increases in social attention
greatly enhance opportunities for learning, serving as a
mediator of the effects of early intervention on later out-
comes that can be measured by standardized tests of
cognitive, language, and adaptive behavior. As such,
measures of social attention could potentially serve as
an early predictor of treatment response in intervention
trials, whether behavioral or pharmacological, in which
enhancement of social motivation/social attention is
presumed to be affected and central to the mechanism
of change.
One of the challenges of clinical trials in autism is the
great variability in responses to intervention. With
respect to behavioral interventions, it is well-established
that there is great individual variability in outcomes,
with some children showing dramatic and rapid gains
and others progressing more slowly. For the latter
group, it is possible that response to a behavioral inter-
vention could be enhanced through pharmacological
intervention that augments social attention or otherwise
improves the tractability of other components of the
treatment plan. A hypothetical adaptive study design for
such an intervention trial is shown in Figure 2. In this
instance, it is suggested that measures of social attention
could potentially serve as a biomarker for stratification
into two arms of a clinical trial (behavioral intervention
augmented with a pharmacological intervention vs.
behavioral intervention alone). If sample size would per-
mit, the design could involve randomization of the sub-
group showing no increase in social attention into either
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(1) continuation with behavioral intervention alone ver-
sus (2) behavioral intervention plus pharmacological
treatment.
How to measure social attention in individuals with ASD
Given the primacy of social attention in the deficits
observed in ASD and its relationship to subsequent
development, the careful assessment and characteriza-
tion of social attention impairments in ASD may pro-
vide insight into which children will respond positively
to interventions that are dependent upon some degree
of social attention. Social attention is strongly related to
joint attention skills, and through joint attention, to sub-
sequent language development [101]. Social attention
remains relatively stable in early years [102], has poten-
tial diagnostic predictive power [6], and can be assessed
at the behavioral and electrophysiological levels. A vari-
ety of behavioral, electrophysiological, and eye tracking
measures have been used to assess social attention
abilities in individuals with ASD. Several have promise
as easy to administer, objective, and informative mea-
sures for potential use as predictive indicators of
response to treatment. These measures are summarized
in Table 1 and described below.
Behavioral measures
At the behavioral level a number of assessment tasks are
appropriate for use with young children with ASD. In
the social orienting task [10] a child is presented with a
variety of auditory stimuli while engaged with an experi-
menter at a table. During the task the child and experi-
menter sit across from each other at a table while a
second experimenter delivers a variety of social (such as
calling the child’s name, clapping hands) and non-social
(such as car horn honking, kitchen timer) sounds from
four locations around the room. Each stimulus lasts
approximately 6 s, is matched on decibel level, and is
delivered once in the child’s left and right visual field
























































Figure 2 Social attention as an early indicator of efficacy in a clinical trial testing combined behavioral and pharmacological
treatment.
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Table 1 Selected methods for measuring social attention in individuals with ASD




(Dawson et al., 1998)
Child is presented social (for example calling
name, clapping hands) and non-social (such
as car horn, kitchen timer) sounds from four
locations around the room. Stimuli are
presented for 6 s at matched decibel levels,
and delivered once in the child’s left and
right visual field and once 30° behind the
child to the left or right. The frequency with
which the child orients to the sound is
tallied
20: 4 to 6-year-olds with
ASD
19: 4 to 6-year-olds with
DS
20: verbal mental age-
matched TYP controls
ASD group oriented less to all stimuli
than controls. This was more






(Mosconi et al., 2009)
SOC-RS provides ratings for four behaviors
related to social orienting: social referencing,
joint attention, orienting to name, and social
smiling, coded based on videotaped
recording of standardized activities
administered during the Autism Diagnostic
Observation Schedule (ADOS). Behaviors are
coded as rate/min and converted to z
scores, except orienting which is scored as
the trial number which orienting occurs. A
total score is compiled by averaging
standardized ratings
53: 18 to 35-month-olds
with ASD; 27 of whom
participate 24 months later
for follow-up
35: age-matched TYP
controls (15 at Time 1 and
20 at Time 2)
Deficits in social referencing, joint
attention, and orienting to name







Task (Pierce et al.,
2011)
Child observes a 1-min video with one side
showing geometric patterns and the other
side showing children in movement (for
example yoga). Total fixation time within




Toddlers with ASD spent more time
fixating on geometric patterns
1 min
Auditory Preference
Task (Kuhl et al.,
2005)
Child is presented with child-directed
speech sounds or frequency and amplitude
matched non-speech sounds from speakers
placed to the left and right of the child. The
number of head turns to the side presenting
non-speech sounds is tallied
29: 2.5 to 4.5-year-olds
with ASD
29: 1 to 4-year-olds mental
age-matched TYP controls
ASD group showed greater preference





(Guiraud et al., 2011)
Child is presented with two different
infrequent (11.5% occurrence each) sounds
(650 Hz pure tone and white noise)
randomly within a sequence of 500-Hz pure
tones. Approximately 500 trials are
presented. Sound intensity is 70 dB SPL and
duration is 100 ms with an inter-stimulus
interval of 700 ms. Average amplitude of
P150 recorded from central electrodes for
repeated and infrequent tones is calculated
as measure of neural habituation
35: 9-month-olds with ASD
siblings (high risk)
21: 9-month-olds with TYP
siblings (low risk)
High-risk infants showed less
habituation to repeated tones and




(Dawson et al., 2004;
Webb et al., 2006)
Child is presented with static pictures of
faces (neutral or fear expressions; familiar
and unfamiliar) of 500 ms duration followed
by a 500-1000 ms inter-trial interval. Fifty
trials of each condition are presented.
Average amplitude and latency of prN170,
N300 recorded and amplitude of Negative
Slow Wave (NSW) from posterior electrodes
for all conditions is calculated




ASD children had longer latency to
prN170 and failed to show differential





(Klin et al., 2002)
Individual views videotape clips of complex
social situations while visual fixation patterns
are recorded
15: teens and adults with
ASD
15: age and verbal IQ
matched TYP controls
Individuals with ASD attended less to
faces and more to objects relative to
controls
10 min
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frequency with which the child orients to the sound is
tallied. Children are also prompted by the examiner to
jointly attend to an object (a star) posted in the four
identified locations throughout the testing room. The
prompt is both verbal (’look’) and visual (point) and the
number of correctly followed joint attention bids is tal-
lied. Children with ASD, compared to typical peers and
children with Down syndrome, more frequently failed to
orient to all stimuli on the social orienting task with
greater impairment for the social stimuli and showed
greater joint attention impairments. Those children with
ASD that did orient to the social stimuli showed delays
in doing so relative to the comparison groups [10].
Additionally, impairments on the social orienting task,
along with impairments in joint attention, best distin-
guished children with ASD from same age typical peers
and peers with developmental delay [101].
The Social Orienting Continuum and Response Scale
(SOC-RS) is a behaviorally based coding measure that
allows for the quantification of social orienting abilities
that are observed during the administration of a struc-
tured play session, the Autism Diagnostic Observation
Scale (ADOS) [102]. During the administration of the
ADOS several presses and activities are utilized in a
standardized way to assess a child’s response to his or
her name, response to joint attention bids, and the fre-
quency and quality with which a child initiates joint
attention. The SOC-RS provides ratings for four beha-
viors related to social orienting, including social referen-
cing, joint attention, orienting to name, and social
smiling that are coded based on the observation of a
videotaped recording of an ADOS administration. In a
longitudinal sample of 2 to 4-year-olds with ASD, Mos-
coni and colleagues found impairments in social referen-
cing, joint attention, and orienting to name relative to
typical peers at 2 years of age and the same impairments
along with deficits in social smiling, the fourth domain,
when the children were 4 years of age [102]. There was
no change over time in the social orienting composite
score derived from the four domains assessed indicating
robust impairments in social orienting over time for
children with ASD.
Visual and auditory preference tasks are other beha-
vioral measures that assess social orienting abilities in
ASD and that could prove informative as a predictive
indicator of subsequent treatment response. In preferen-
tial looking tasks, two visual images or types of images,
such as social scenes or toys, are simultaneously pre-
sented to a child and the total time the child spends
looking at each image is tallied. A percentage of looking
time to each type of image can then be calculated as an
indicator of visual preferences. When presented with 1
min videos of moving geometric patterns displayed on
one side of a monitor and children doing yoga on the
other, toddlers with ASD ranging from 14 to 42 months
spent more time looking at the geometric patterns rela-
tive to the social scenes than same age typical peers and
peers with developmental delay [6]. Further, the positive
predictive value for classifying a toddler with ASD was
100% if the toddler spent more than 69% of the time
watching the geometric pattern. Auditory preference
tasks involve the presentation of sounds, such as speech
and non-speech sounds, via speakers placed on alternate
sides of a child. The number of head turns in the direc-
tion of the two stimuli types can be tallied. Kuhl and
colleagues utilized an auditory preference task in which
young children with autism and typical peers oriented
to a loudspeaker to the left and right that presented
either child-directed speech sounds or frequency and
amplitude matched non-speech sounds [5]. During four
familiarization trials in which the sound types were
alternated, a light atop one of the loudspeakers was
turned on and when the child oriented to the light, the
sound was presented. The side on which the sound type
was presented was counterbalanced. During testing
trials, when the child made a 30° head turn toward the
light, the sound was activated. The number of head
turns to the side presenting non-speech sounds was tal-
lied. Young children with ASD showed a greater prefer-
ence for the non-speech sounds than their typical peers.
Further, when the children with ASD were divided into
two groups (a group that preferred non-speech stimuli
and a group that preferred speech stimuli), those pre-
schoolers that did orient to speech sounds demonstrated
more typical electrophysiological functioning as mea-
sured with an ERP index of stimulus change processing.
Electrophysiological measures
The use of electrophysiological measures, such as the
ERP response to faces, is another potential early indica-
tor of efficacy. Pre-pulse inhibition, for example, has
Table 1 Selected methods for measuring social attention in individuals with ASD (Continued)
Spontaneous eye
blinking (Shultz et al.,
2011)
Toddlers view a video showing physical
movements of objects (for example door on
toy wagon) and affective social interactions
(such as an argument between children).
Instantaneous blink rate and timing of blink
inhibition as a function of viewer
engagement and stimulus type is recorded
41: 2-year-olds with ASD
52: age-matched TYP
controls
TYP toddlers inhibited blinking earlier
than ASD toddlers indicating reduced
anticipation of upcoming salient
information in ASD
2 min
ASD, autism spectrum disorder; DS, Down syndrome; DD, developmental delay; TYP, typical development; FRAX, fragile X syndrome.
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been proposed as an outcome measure in clinical trials
in individuals with fragile X syndrome [103]. ERP para-
digms do not rely on language or behavioral responses
beyond passive viewing, making these paradigms excel-
lent for infants or children of all functioning levels.
Habituation tasks might reflect social attention pro-
cesses. In habituation paradigms, the repeated presenta-
tion of a stimulus results in decreased attention to that
stimulus, providing insight into the perceptual and cog-
nitive abilities of young children. High-risk infants
(infant siblings of children with ASD) showed decreased
habituation to repeated presentations of pure tones as
indexed by an early ERP component relative to same-
age peers with typically developing older siblings.
Further, when presented with a deviant auditory stimu-
lus, the high-risk infants did not show the same ampli-
tude increase of the ERP component as their low-risk
peers [104]. This reduced habituation to repeated sti-
muli and the corresponding attenuated response to sti-
mulus change may play a role in the reduced sensitivity
to social stimuli and the orienting deficits observed in
ASD.
Face-related ERPs also could reflect social attention
processes [12]. Such paradigms involve the presentation
of faces, either upright or inverted, with neutral or emo-
tional expressions, or that are familiar or unfamiliar,
along with the presentation of comparison stimuli, such
as toys, cars, or houses. Latency and amplitude of select
ERP components, such as the face specific N170, can
then be analyzed. Compared to typically developing and
developmentally delayed peers, individuals with ASD fail
to show amplitude changes in negative going waves
approximately 300 ms after the presentation of neutral
and fearful faces [105,106] and show increased latencies
in the early negative going N170 component in response
to the observation of upright and inverted faces [107].
Indeed, a computerized face-training intervention has
been shown to modulate the ERP response to faces in
adults with ASD, underscoring the utility of ERP para-
digms as a measure of treatment response [108]. Adults
with ASD underwent an 8-week face expertise training
intervention with ERP and behavioral assessments con-
ducted before and after intervention. The intervention
resulted in behavioral improvements in face recognition
and modulated the P1 amplitude in response to viewing
faces [108].
Eye tracking measures
Eye-tracking technology provides another avenue to
assess social attention in ASD. Eye-tracking is being
actively explored as an outcome measure in ASD clinical
trials (for example, http://www.clinicaltrials.gov/ct2/
show/NCT01425918?term=eye-tracking&rank=7).
Through cameras that non-invasively capture the move-
ment of the eye, measurements of viewing patterns can
be recorded and time spent fixating or looking at parts
of static images or places in a dynamic scene can be
quantified for analysis. Pioneering work assessing gaze
and fixation patterns in individuals with ASD indicated
decreased attention to faces and increased attention to
objects in social scenes with the added finding that the
amount of time spent looking at objects correlated with
social impairment [109]. Further work combining eye-
tracking technology with a preferential looking paradigm
has indicated that toddlers with ASD fail to show a pre-
ference for point-light depictions of biological motion
over scrambled point light motion as typical toddlers do
[11].
Shultz, Klin, and Jones [110] recently reported on a
novel measure of social attention/engagement derived
from eye-tracking paradigms. They measured sponta-
neous eye blinking in toddlers with ASD and those with
typical development while the toddlers watched a video-
tape containing segments displaying primary physical
motion versus emotionally-laden interactions between
two other toddlers. They found that both groups modu-
lated the timing of blink inhibition when watching the
tape, compared to a baseline period. Whereas typical
toddlers showed greater blink inhibition during the
social scene than during the non-social scene, toddlers
with ASD showed the reversed pattern. Measures of
blink inhibition can potentially serve as indices of per-
ceived stimulus salience and can, therefore, be helpful
measures of social attention/engagement in young chil-
dren with ASD. Future studies are needed to determine
whether the patterns of blink inhibition found by Shultz
et al. are consistent throughout development.
Conclusions
Autism is characterized by early-emerging impairments
in social attention believed to be related to a reduced
sensitivity to the reward value of social stimuli. Such
impairments in social attention can have substantial det-
rimental impact on subsequent learning and neural
development and specialization. Early behavioral inter-
vention serves to increase children’s attention to and
enjoyment of social interactions, thereby increasing
opportunities for learning and helping steer brain and
behavioral development back toward the normal trajec-
tory [19]. Oxytocin may enhance social engagement and
attention in persons with ASD through its effects of
neural circuitry related to social reward. Attention is
closely related to the reward value of stimuli, activating
the ACC which is known to mediate attention and be a
key region involved in reward processing. We have
hypothesized that measures of social attention could
serve as a moderator or mediator in autism clinical
trials, and may serve as an early read-out of efficacy and
as a means of decision-making in an adaptive trial.
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Future research will be needed to validate the utility of
social attention when used in this manner.
Endnotes
aA biomarker has been defined as any characteristic that
is objectively measured and evaluated as an indicator of
normal biological processes, pathogenetic processes, or
pharmacological responses to a therapeutic intervention.
Thus, biomarkers can be behaviors or physiological
traits that indicate early response to an intervention and
need not be a biological measure. Social attention can
be measured using behavioral (such as eye-tracking) or
physiological (such as event-related potentials) indices.
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